POS-323 INSIDE CKD: PROJECTING THE FUTURE BURDEN OF CHRONIC KIDNEY DISEASE IN EUROPE USING MICROSIMULATION MODELLING

• J.J. GARCIA SANCHEZ,
• A. Power,
• A. Abdul Sultan,
• J. Ärnlöv,
• C. Cabrera,
• L. De Nicola,
• J.M. Halimi,
• F.S. Mennini,
• J.F. Navarro-González,
• S. Nolan,
• L. Retat,
• L. Webber,
• M. Xu

Affiliations

J.J. GARCIA SANCHEZ

AstraZeneca, Health Economics, Cambridge, United Kingdom

A. Power

North Bristol NHS Trust, Renal Medicine, Bristol, United Kingdom

A. Abdul Sultan

AstraZeneca, Epidemiology, Cambridge, United Kingdom

J. Ärnlöv

Karolinska Institutet - Division of Family Medicine and Primary Care, Department of Neurobiology- Care Sciences and Society, Stockholm, Sweden

C. Cabrera

AstraZeneca, Epidemiology & Evidence Excellence, Gothenburg, Sweden

L. De Nicola

University Luigi Vanvitelli, Department of Advanced Medical and Surgical Sciences, Naples, Italy

J.M. Halimi

University Hospital of Tours, Nephrology & Transplantation ward, Tours, France

F.S. Mennini

University of Rome ''Tor Vergata'', EEHTA CEIS- Faculty of Economics, Rome, Italy

J.F. Navarro-González

University Hospital Nuestra Señora de Candelaria, Research Unit & Nephrology Service, Santa Cruz de Tenerife, Spain

S. Nolan

AstraZeneca, Diabetes, Cambridge, United Kingdom

L. Retat

HealthLumen, Microsimulation modelling, London, United Kingdom

L. Webber

HealthLumen, Microsimulation modelling, London, United Kingdom

M. Xu

HealthLumen, Microsimulation modelling, London, United Kingdom